Cargando…

4H leukodystrophy: Mild clinical phenotype and comorbidity with multiple sclerosis

Detalles Bibliográficos
Autores principales:	DeGasperis, Stephanie M., Bernard, Geneviève, Wolf, Nicole I., Miller, Elka, Pohl, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2020
Materias:	Clinical/Scientific Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164972/ https://www.ncbi.nlm.nih.gov/pubmed/32337336 http://dx.doi.org/10.1212/NXG.0000000000000409

Ejemplares similares

Lysosomal dysfunction in TMEM106B hypomyelinating leukodystrophy
por: Ito, Yoko, et al.
Publicado: (2018)

Tumefactive inflammatory lesions in juvenile metachromatic leukodystrophy
por: Meier, Kolja, et al.
Publicado: (2020)

The First Korean Siblings With Adult-Onset 4H Leukodystrophy Related to Nonsynonymous POLR3B Mutations
por: Yang, Hui-Jun, et al.
Publicado: (2022)

Myelopathy in a patient with leukodystrophy due to CSF1R mutation
por: Ho, Victoria M., et al.
Publicado: (2019)

Severe Epilepsy and Movement Disorder May Be Early Symptoms of TMEM106B-Related Hypomyelinating Leukodystrophy
por: Solazzi, Roberta, et al.
Publicado: (2022)

Cortical interneuron development is affected in 4H leukodystrophy
por: Dooves, Stephanie, et al.
Publicado: (2023)

Phenotypic variation between siblings with Metachromatic Leukodystrophy
por: Elgün, Saskia, et al.
Publicado: (2019)

Endocrine Aspects of 4H Leukodystrophy: A Case Report and Review of the Literature
por: Billington, Emma, et al.
Publicado: (2015)

Expanding the phenotypic and molecular spectrum of RNA polymerase III–related leukodystrophy
por: Perrier, Stefanie, et al.
Publicado: (2020)

4H leukodystrophy caused by a homozygous POLR3B mutation: Further delineation of the phenotype
por: Verberne, Eline A., et al.
Publicado: (2020)

Pathology of the neurovascular unit in leukodystrophies
por: Zarekiani, Parand, et al.
Publicado: (2021)

POLR3-Related Leukodystrophy: Exploring Potential Therapeutic Approaches
por: Perrier, Stefanie, et al.
Publicado: (2021)

Multiple sclerosis–like lesions and type I interferon signature in a patient with RVCL
por: Schuh, Elisabeth, et al.
Publicado: (2014)

Intrathecal baclofen in metachromatic leukodystrophy
por: van der Veldt, Nikki, et al.
Publicado: (2018)

Three novel variants in the arylsulfatase A (ARSA) gene in patients with metachromatic leukodystrophy (MLD)
por: Hettiarachchi, D., et al.
Publicado: (2019)

Diffusion tensor imaging in metachromatic leukodystrophy
por: van Rappard, Diane F., et al.
Publicado: (2018)

Neurogenic bladder and neuroendocrine abnormalities in Pol III-related leukodystrophy
por: Potic, Ana, et al.
Publicado: (2015)

Lymphopenia in treatment-naive relapsing multiple sclerosis
por: Lim, Zhi Wei, et al.
Publicado: (2016)

RARS1‐related hypomyelinating leukodystrophy: Expanding the spectrum
por: Mendes, Marisa I., et al.
Publicado: (2019)

Large exonic deletions in POLR3B gene cause POLR3-related leukodystrophy
por: Gutierrez, Mariana, et al.
Publicado: (2015)

Severe Neuroinvasive West Nile Virus in Association With Anti-CD20 Monotherapy for Multiple Sclerosis
por: Thebault, Simon, et al.
Publicado: (2023)

Unusual deterioration in a patient with multiple sclerosis on natalizumab therapy
por: Gattringer, Thomas, et al.
Publicado: (2014)

Progressive hemiparesis (Mills syndrome) with aphasia in amyotrophic lateral sclerosis
por: Bäumer, Dirk, et al.
Publicado: (2014)

Monozygotic twins discordant for narcolepsy type 1 and multiple sclerosis
por: Jennum, Poul J., et al.
Publicado: (2016)

Disseminated Histoplasmosis in a Patient With Multiple Sclerosis Treated With Fingolimod
por: Abrahamowicz, Aleksandra A., et al.
Publicado: (2021)

Natalizumab Promotes Activation of Peripheral Monocytes in Patients With Multiple Sclerosis
por: Frisch, Esther S., et al.
Publicado: (2023)

A distinct phenotype of childhood leukodystrophy presenting as absence seizure
por: Dweikat, Imad Mohammad, et al.
Publicado: (2014)

Redefining the phenotype of ALSP and AARS2 mutation–related leukodystrophy
por: Lakshmanan, Rahul, et al.
Publicado: (2017)

Multi-Voxel 1H-MRS in Metachromatic Leukodystrophy
por: Assadi, Mitra, et al.
Publicado: (2013)

Phenotypic convergence of Menkes and Wilson disease
por: Bansagi, Boglarka, et al.
Publicado: (2016)

CNS inflammation other than multiple sclerosis: How likely is diagnosis?
por: Street, Duncan, et al.
Publicado: (2014)

Nonfatal PML in a patient with multiple sclerosis treated with dimethyl fumarate
por: Baharnoori, Moogeh, et al.
Publicado: (2016)

Severe paradoxical disease activation following alemtuzumab treatment for multiple sclerosis
por: Brannigan, Jamie, et al.
Publicado: (2020)

COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
por: Barzegar, Mahdi, et al.
Publicado: (2020)

Refractory chronic spontaneous urticaria after the use of alemtuzumab in multiple sclerosis
por: Hu, Hannah, et al.
Publicado: (2020)

Questioning the Association of the STMN2 Dinucleotide Repeat With Amyotrophic Lateral Sclerosis
por: Ross, Jay P., et al.
Publicado: (2022)

Whole-exome sequencing identifies mutations in MYMK in a mild form of Carey-Fineman-Ziter syndrome
por: Alrohaif, Hadil, et al.
Publicado: (2018)

Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective
por: Beerepoot, Shanice, et al.
Publicado: (2019)

Disseminated zoster with paresis in a multiple sclerosis patient treated with dimethyl fumarate
por: Ma, Brandy B., et al.
Publicado: (2016)

Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy
por: Rust, Heiko, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b0jbgu194sl3ldecfjr6vpnsse